DBV Technologies. (DBVT) NASDAQ

$0.70 0 (0.09%)

Market Cap: $133.95M

As of 04/15/24 03:59 PM EDT. Market closed.

(DBVT)

DBV Technologies. (DBVT)
NASDAQ

$0.70
0 (0.09%)

Market Cap: $133.95M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

dbv technologies is opening up a decisive new approach to the treatment of allergy – a major public health issue that is constantly increasing in prevalence. food allergies represent a true handicap in everyday life for millions of people and thus constitute a major unmet medical need. dbv technologies (incorporated in 2002) has developed a unique, proprietary, worldwide-patented technology for ... read more

dbv technologies is opening up a decisive new approach to the treatment of allergy – a major public health issue that is constantly increasing in prevalence. food allergies represent a true handicap in everyday life for millions of people and thus constitute a major unmet medical need. dbv technologies (incorporated in 2002) has developed a unique, proprietary, worldwide-patented technology for administering an allergen to intact skin and avoiding massive transfer to the blood. the viaskin® technology combines efficacy and safety as part of a treatment that seeks to improve the patient's tolerability of peanut and thus considerably lower the risk of a systemic, allergic reaction in the event of accidental exposure to the allergen. the product's clinically proven safety of use enables the application of effective desensitization techniques (the efficacy of which is acknowledged worldwide) in the most severe forms of the allergy. dbv technologies is focusing on food allergies (milk and read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Daniel Tasse
Full Time Employees
178
URL
Address
177-181 avenue Pierre Brossolette, Ile De France, Montrouge, 92120.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Daniel Tasse
Full Time Employees
178
Address
177-181 avenue Pierre Brossolette, Ile De France, Montrouge, 92120.
PRICE CHART FOR DBV TECHNOLOGIES
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.70
Previous Close
$0.69
Days Range
$0.69 - $0.72
52 week range
$0.65 - $2.37
Volume
26,064
Avg. Volume (30 days)
51,907
Market Cap
$133.95M
Dividend Yield
-
P/E
-
Shares Outstanding
192,868,738
Open
$0.70
Previous Close
$0.69
Days Range
$0.69 - $0.72
52 week range
$0.65 - $2.37
Volume
26,064
Avg. Volume (30 days)
51,907
Market Cap
$133.95M
Dividend Yield
-
P/E
-
Shares Outstanding
192,868,738
FINANCIAL STATEMENTS FOR DBV TECHNOLOGIES
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DBV TECHNOLOGIES
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Tasse DanielCHIEF EXECUTIVE OFFICERMar 08, 2024 Buy$0.8317,09414,18817,094Mar 11, 2024, 04:15 PM
Ndu AdoraDirectorFeb 06, 2024 Buy$0.891,8251,6241,825Feb 08, 2024, 05:02 PM
Mohideen PharisChief Medical OfficerNov 22, 2023 Sale$1.742,2453,90682,194Dec 19, 2023, 04:44 PM
MORRIS TIMOTHY EDirectorAug 25, 2023 Buy$1.5212,00018,24012,000Aug 28, 2023, 04:35 PM
Mohideen PharisChief Medical OfficerMay 24, 2023 Sale$3.544691,66049,439Aug 14, 2023, 04:32 PM
Mohideen PharisChief Medical OfficerNov 24, 2022 Sale$2.881,7925,16149,908Aug 14, 2023, 04:32 PM
SOLAND DANIEL BDirectorAug 01, 2023 Buy$1.6215,00024,30020,000Aug 03, 2023, 04:40 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Tasse DanielCHIEF EXECUTIVE OFFICER03/08/202414,188
Ndu AdoraDirector02/06/20241,624
Mohideen PharisChief Medical Officer11/22/20233,906
MORRIS TIMOTHY EDirector08/25/202318,240
Mohideen PharisChief Medical Officer05/24/20231,660
Mohideen PharisChief Medical Officer11/24/20225,161
SOLAND DANIEL BDirector08/01/202324,300
FUNDS WITH A POSITION IN DBV TECHNOLOGIES
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP14,614,2640.16%No changeOther
YIHENG CAPITAL MANAGEMENT, L.P.5,241,5640.29%3835.34%Other
VIVO CAPITAL, LLC2,708,8750.21%No changeOther
GEODE CAPITAL MANAGEMENT, LLC38,7790%63.86%Other
CHANGE IN SHARES OUTSTANDING FOR DBV TECHNOLOGIES
STOCK BUYBACKS FOR DBV TECHNOLOGIES
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.01%
1Q
12/31/2023
06/30/2023
1.86%
2Q
12/31/2023
03/31/2023
2.25%
3Q
12/31/2023
12/31/2022
24.16%
4Q
12/31/2023
09/30/2022
2.32%
5Q
12/31/2023
06/30/2022
45.47%
6Q
12/31/2023
03/31/2022
74.91%
7Q
12/31/2023
12/31/2021
74.90%
8Q
12/31/2023
09/30/2021
74.86%
9Q
12/31/2023
06/30/2021
75.00%
10Q
12/31/2023
03/31/2021
75.07%
11Q
12/31/2023
12/31/2020
75.28%
12Q
12/31/2023
09/30/2020
75.19%
13Q
12/31/2023
06/30/2020
75.09%
14Q
12/31/2023
03/31/2020
85.48%
15Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.01%
1Q
06/30/2023
1.86%
2Q
03/31/2023
2.25%
3Q
12/31/2022
24.16%
4Q
09/30/2022
2.32%
5Q
06/30/2022
45.47%
6Q
03/31/2022
74.91%
7Q
12/31/2021
74.90%
8Q
09/30/2021
74.86%
9Q
06/30/2021
75.00%
10Q
03/31/2021
75.07%
11Q
12/31/2020
75.28%
12Q
09/30/2020
75.19%
13Q
06/30/2020
75.09%
14Q
03/31/2020
85.48%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR DBV TECHNOLOGIES
LOADING...